hotspot -WSS

hotspot

author：explore 2025-08-12 08:27:24 - browse：3331

An army of wooden figures under blue and pink lighting — biotech coverage from STAT — Adobe

Biotech startup ReNAgade Therapeutics is cutting staff just seven months after raising the largest Series A round in the industry this year.

ReNAgade launched in May with hopes of becoming a one-stop shop for medicines targeting RNA, the genetic blueprints that cells use to make proteins instrumental in numerous diseases. These types of medicines are in high demand following the advent of mRNA vaccines for Covid and RNA-silencing therapies made by companies like Alnylam Pharmaceuticals.

ReNAgade was able to capitalize on that excitement when it raised a $300 million Series A round led by MPM Capital’s BioImpact Capital and F2 Ventures. But in recent days, the company decided to lay off around 10% of its 100-person team, according to a company statement and former employees’ posts on social media.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： The inclusion problem at the heart of rehabilitation research

WSS

Drinking less cuts risk of oral cavity, esophageal cancer: Report

Maisha Meds is a PBM, but don't call it that

HPV vaccine, cervical cancer study delivers historic results

Inaction leaves children at risk from dangerous chemotherapy drug

Albert Bourla of Pfizer: worst biopharma CEO of 2023

Medicare Advantage beneficiaries sue Humana over algorithm use

leisure time

hotspot

entertainment

Tori Bowie and the unacceptable rates of Black maternal death

Bristol Myers buys into radiopharmaceuticals with RayzeBio

Medical leaders decry Supreme Court decision on affirmative action

Update the Apgar Score to remove skin color

Anesthesiologist group: stop taking Ozempic before surgery

Head of FDA's diagnostics center, who led through Covid, retires

Medical records are filled with copy

Future doctors need a strong humanities education

Trump demands the U.S. pay no more for drugs than other countries … again

Printout prescription drug information shouldn’t go digital

leisure time

Carvykti CAR

Medicare Advantage beneficiaries sue Humana over algorithm use

Why health records don't always know when patients are dead

Medicare drug price lawsuits could be good politics for Biden

Dana Farber says 6 studies to be retracted and 31 corrected

Why health records don't always know when patients are dead

focus

knowledge

leisure time

focus